BORTEZOMIB-PINANEDIOL structure
|
Common Name | BORTEZOMIB-PINANEDIOL | ||
|---|---|---|---|---|
| CAS Number | 205393-22-2 | Molecular Weight | 518.455 | |
| Density | 1.2±0.1 g/cm3 | Boiling Point | 719.5±60.0 °C at 760 mmHg | |
| Molecular Formula | C29H39BN4O4 | Melting Point | 75-83ºC | |
| MSDS | N/A | Flash Point | 389.0±32.9 °C | |
Use of BORTEZOMIB-PINANEDIOLBortezomib-pinanediol is a prodrug of Bortezomib, as well as a proteasome inhibitor. |
| Name | bortezomib-pinanediol |
|---|---|
| Synonym | More Synonyms |
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Boiling Point | 719.5±60.0 °C at 760 mmHg |
| Melting Point | 75-83ºC |
| Molecular Formula | C29H39BN4O4 |
| Molecular Weight | 518.455 |
| Flash Point | 389.0±32.9 °C |
| Exact Mass | 518.306458 |
| PSA | 102.44000 |
| LogP | 4.81780 |
| Vapour Pressure | 0.0±2.3 mmHg at 25°C |
| Index of Refraction | 1.572 |
|
~%
BORTEZOMIB-PINA... CAS#:205393-22-2 |
| Literature: Journal of Medicinal Chemistry, , vol. 54, # 13 p. 4365 - 4377 |
|
~%
BORTEZOMIB-PINA... CAS#:205393-22-2 |
| Literature: Journal of Medicinal Chemistry, , vol. 54, # 13 p. 4365 - 4377 |
|
~%
BORTEZOMIB-PINA... CAS#:205393-22-2 |
| Literature: Journal of Medicinal Chemistry, , vol. 54, # 13 p. 4365 - 4377 |
|
~%
BORTEZOMIB-PINA... CAS#:205393-22-2 |
| Literature: Journal of Medicinal Chemistry, , vol. 54, # 13 p. 4365 - 4377 |
|
~%
BORTEZOMIB-PINA... CAS#:205393-22-2 |
| Literature: Journal of Medicinal Chemistry, , vol. 54, # 13 p. 4365 - 4377 |
|
~%
BORTEZOMIB-PINA... CAS#:205393-22-2 |
| Literature: Journal of Medicinal Chemistry, , vol. 54, # 13 p. 4365 - 4377 |
|
~%
BORTEZOMIB-PINA... CAS#:205393-22-2 |
| Literature: WO2012/48745 A1, ; |
|
~%
BORTEZOMIB-PINA... CAS#:205393-22-2 |
| Literature: Bioorganic and Medicinal Chemistry, , vol. 21, # 4 p. 1018 - 1029 |
|
~%
BORTEZOMIB-PINA... CAS#:205393-22-2 |
| Literature: Journal of Medicinal Chemistry, , vol. 54, # 13 p. 4365 - 4377 |
| Precursor 9 | |
|---|---|
| DownStream 1 | |
| Bortezomib pinanediol ester |
| 2-Pyrazinecarboxamide, N-[(1S)-2-[[(1R)-1-[(3aS,4S,6S,7aR)-hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl]-3-methylbutyl]amino]-2-oxo-1-(phenylmethyl)ethyl]- |
| N-{(1R)-3-Methyl-1-[(1S,2S,6R,8S)-2,9,9-trimethyl-3,5-dioxa-4-boratricyclo[6.1.1.0]dec-4-yl]butyl}-Nα-(2-pyrazinylcarbonyl)-L-phenylalaninamide |
| Bortezomib intermediates III |